CBD for Anxiety: Evidence-Based Recommendation
Current evidence does not support recommending CBD for anxiety in otherwise healthy adults, as high-quality guidelines and recent clinical trials show insufficient efficacy, potential psychiatric harms including worsening anxiety, and documented risks of cannabis use disorder. 1, 2
Why CBD Should Not Be Recommended
Insufficient Evidence for Efficacy
- The 2023 MASCC systematic review concluded that no recommendation was possible regarding use of cannabis for anxiety or depression in clinical populations 1
- A 2023 randomized controlled trial testing CBD doses of 150,300, and 600 mg found no effect on anxiety symptoms compared to placebo 3
- The American College of Physicians notes that cannabis may be associated with increased risk for developing anxiety and depressive disorders 1
Documented Psychiatric Risks
- Cannabis use is associated with increased risk for developing and exacerbating anxiety disorders, with approximately 10% of chronic users developing cannabis use disorder 2
- Chronic cannabis use carries long-term psychiatric risks that may be correlated with cumulative exposure, and can exacerbate psychiatric disorders in vulnerable individuals 1
- Cannabis provides no proven benefit for anxiety and carries well-documented psychiatric harms 2
Cardiovascular and Other Safety Concerns
- Cardiovascular side effects may include arrhythmias and orthostatic hypotension 1
- In older adults, acute cannabis toxicity may be associated with sedation, obtundation, and myocardial ischemia or infarction 1
- Common side effects include dizziness, confusion, dry mouth, and fatigue 1
Evidence-Based Treatment Alternatives
First-Line Pharmacotherapy
- Initiate an SSRI (escitalopram or sertraline) for moderate to severe anxiety (GAD-7 ≥10) 2
- SSRIs have robust evidence for efficacy and should be continued for at least 12 months after symptom remission 2
- Reassess at 4 weeks; if no improvement by 8 weeks at adequate dose, switch to a different SSRI or SNRI 2
Psychotherapy
- Cognitive Behavioral Therapy (CBT) is the psychotherapy with the strongest evidence for anxiety disorders, with large effect sizes (Hedges g = 1.01 for GAD) 2
- Combining pharmacotherapy and psychotherapy may be necessary for optimal outcomes 2
Assessment Tools
- Use GAD-7 scale to establish baseline severity: 0-4 (none/mild), 5-9 (moderate), 10-14 (moderate-to-severe), 15-21 (severe) 2
- Screen for depression using PHQ-9 given high comorbidity 2
Nuances in the Evidence
Conflicting Research Data
While some older preclinical evidence (2015) suggested CBD might have potential for anxiety disorders 4, and small open-label studies showed improvements 5, 6, these findings have not been replicated in rigorous placebo-controlled trials 3. The most recent high-quality randomized controlled trial (2023) found no anxiolytic effect 3.
Cancer Population Exception
The only context where cannabinoids have limited evidence is in cancer patients with refractory chemotherapy-induced nausea and vomiting, but even here, evidence for anxiety management remains insufficient 1
Hepatotoxicity Risk
CBD doses ≥300 mg/day are associated with reversible liver enzyme abnormalities, with a nearly 6-fold increase in liver enzyme elevation and drug-induced liver injury 1
Critical Clinical Pitfalls
- Do not recommend cannabis for anxiety management—evidence is insufficient for efficacy and risks are well-documented 2
- Do not assume CBD is "natural" and therefore safe; it carries documented risks of substance use disorder, psychiatric harm, and cardiovascular events 1, 2
- Screen for current cannabis use, as cessation is essential for anxiety improvement 2
- If patients are using cannabis, counseling to achieve marijuana cessation is the mainstay of long-term management 2
Patient Education Points
- Educate that cannabis does not treat anxiety and may worsen symptoms or cause panic attacks 2
- Explain that substance cessation (cannabis, alcohol, caffeine) is essential for anxiety improvement 2
- Provide information about evidence-based treatments (SSRIs and CBT) with proven efficacy 2
- For patients insisting on trying CBD despite counseling, warn about lack of proven benefit, potential for worsening anxiety, and risk of developing cannabis use disorder 1, 2